Today: 1 July 2026
Browse Category

NASDAQ:SPRC 26 September 2025 - 5 December 2025

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc Ltd. is back on traders’ radar after a frenetic week of news that spans quantum bio‑data analytics, medical endoscopy devices and ongoing restructuring of its biotech portfolio. As of Friday, December 5, 2025, SciSparc shares are trading around $1.79–$1.80, after an early pre‑market jump of about 19% to $2.10, on volume that has already surged well above normal levels. StockAnalysis+1
SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

Key facts SciSparc’s new program aims to apply quantum algorithms to hard problems in protein folding and protein–ligand interactions, with the goal of more precise simulations that speed discovery in neurological and rare diseases. The board authorized creating a wholly‑owned Israeli subsidiary to run the effort and to pursue IP around the methods. GlobeNewswire
26 September 2025

Stock Market Today

  • UiPath jumps 8% as buybacks, short bets and trading action drive move
    July 1, 2026, 3:07 PM EDT. UiPath Inc (NYSE:PATH) climbed over 8% to $11.77 with trading volumes spiking and short interest at 32.23% of float in mid-June. Around 42% of the float changed hands over three sessions, showing a flurry of trading. PATH outperformed software ETF IGV, up 3.9%, while QQQ slipped. UBS put a $12 price target, nearly matching PATH's last trade, calling sentiment cautious after shares fell 28% this year. Q1 filings showed a 17% revenue gain and strong cash, giving some fundamental lift. No fresh earnings came out, pointing to buybacks and shorts as likely drivers behind the rally.
Go toTop